LAMEA IV Dressing Market Size, Share & Trends Analysis Report By Type (Transparent, and Translucent), By End-use (Hospitals, Clinics, and Others), By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa IV Dressing Market would witness market growth of 8.5% CAGR during the forecast period (2024-2031). In the year 2027, the LAMEA market's volume is expected to surge to 3,859.5 thousand units, showcasing a growth of 9.9% (2024-2031).

Translucent IV dressings represent a significant segment within the market, offering unique advantages for healthcare professionals and patients alike. These dressings feature a semi-transparent material that allows partial visibility of the insertion site, enabling clinicians to assess the condition without fully removing the dressing. Therefore, the Brazil market consumed 171.4 thousand units of Translucent IV dressings in 2023.



The Brazil market dominated the LAMEA IV Dressing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $25.9 Million by 2031. The Argentina market is showcasing a CAGR of 9% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 8.1% during (2024 - 2031).

Transparent dressings are becoming increasingly popular due to their ability to provide visibility of the insertion site without the need for frequent dressing changes. As more healthcare services are delivered outside traditional hospital settings, there is a growing demand for dressings suitable for home healthcare settings. Manufacturers are developing products that are easy for patients or caregivers to apply, remove, and provide reliable protection and comfort during extended wear.

Eco-friendly solutions are in higher demand as healthcare professionals become more conscious of environmental sustainability. Integrating smart technologies, such as sensors and indicators, into dressings is an emerging trend. These technologies enable real-time monitoring of parameters such as temperature, moisture levels, and pH at the insertion site, allowing for early detection of complications and proactive intervention to improve patient outcomes.

As per the National Library of Medicine, the Middle East has a high rate of cardiovascular disease (10.1%). In this region, the prevalence of dyslipidemia (43.3%) is double that of hypertension (26.2%) and diabetes mellitus (16%). Multifaceted interventions are desperately needed in this region for CVD primary prevention. Cardiovascular diseases contribute to a significant proportion of hospital admissions in the Middle East. Patients with acute cardiovascular conditions or complications may require hospitalization for diagnostic procedures, interventions, and monitoring in the Middle East. Elderly patients with cardiovascular conditions often require complex medical management and may experience frequent hospitalizations for cardiovascular events or complications in the Middle East. Thus, due to these aspects, the market will expand across the LAMEA region in upcoming years.

Based on Type, the market is segmented into Transparent, and Translucent. Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• 3M Company
• Cardinal Health, Inc.
• Smith & Nephew PLC
• McKesson Corporation
• Covalon Technologies Ltd.
• Becton, Dickinson, and Company
• Molnlycke Health Care AB
• DermaRite Industries, LLC
• Dynarex Corporation
• Essity AB (BSN medical)

Market Report Segmentation

By Type (Volume, Thousand Units, USD Billion, 2020-2031)

• Transparent
• Translucent

By End-use (Volume, Thousand Units, USD Billion, 2020-2031)

• Hospitals
• Clinics
• Others

By Country (Volume, Thousand Units, USD Billion, 2020-2031)

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA